241 related articles for article (PubMed ID: 12394782)
1. HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes.
Anderson E; Zink W; Xiong H; Gendelman HE
J Acquir Immune Defic Syndr; 2002 Oct; 31 Suppl 2():S43-54. PubMed ID: 12394782
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: relevance for HIV-1-associated dementia.
Xiong H; Zeng YC; Lewis T; Zheng J; Persidsky Y; Gendelman HE
J Neurovirol; 2000 May; 6 Suppl 1():S14-23. PubMed ID: 10871761
[TBL] [Abstract][Full Text] [Related]
3. Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia.
Persidsky Y; Zheng J; Miller D; Gendelman HE
J Leukoc Biol; 2000 Sep; 68(3):413-22. PubMed ID: 10985259
[TBL] [Abstract][Full Text] [Related]
4. The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes.
Zheng J; Gendelman HE
Curr Opin Neurol; 1997 Aug; 10(4):319-25. PubMed ID: 9266156
[TBL] [Abstract][Full Text] [Related]
5. Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection.
Persidsky Y; Gendelman HE
J Leukoc Biol; 2003 Nov; 74(5):691-701. PubMed ID: 14595004
[TBL] [Abstract][Full Text] [Related]
6. Macrophages, chemokines and neuronal injury in HIV-1-associated dementia.
Ryan LA; Cotter RL; Zink WE; Gendelman HE; Zheng J
Cell Mol Biol (Noisy-le-grand); 2002 Mar; 48(2):137-50. PubMed ID: 11995633
[TBL] [Abstract][Full Text] [Related]
7. HIV-1-associated dementia: a basic science and clinical perspective.
Diesing TS; Swindells S; Gelbard H; Gendelman HE
AIDS Read; 2002 Aug; 12(8):358-68. PubMed ID: 12229893
[TBL] [Abstract][Full Text] [Related]
8. Soluble HIV-1 infected macrophage secretory products mediate blockade of long-term potentiation: a mechanism for cognitive dysfunction in HIV-1-associated dementia.
Xiong H; Zeng YC; Zheng J; Thylin M; Gendelman HE
J Neurovirol; 1999 Oct; 5(5):519-28. PubMed ID: 10568889
[TBL] [Abstract][Full Text] [Related]
9. Microglia in HIV-associated neurological diseases.
Glass JD; Wesselingh SL
Microsc Res Tech; 2001 Jul; 54(2):95-105. PubMed ID: 11455616
[TBL] [Abstract][Full Text] [Related]
10. Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases.
Yoshioka M; Bradley WG; Shapshak P; Nagano I; Stewart RV; Xin KQ; Srivastava AK; Nakamura S
Adv Neuroimmunol; 1995; 5(3):335-58. PubMed ID: 8748077
[TBL] [Abstract][Full Text] [Related]
11. Similarity of neuronal cell injury and death in AIDS dementia and focal cerebral ischemia: potential treatment with NMDA open-channel blockers and nitric oxide-related species.
Lipton SA
Brain Pathol; 1996 Oct; 6(4):507-17. PubMed ID: 8944320
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-induced inflammation affects hippocampal plasticity and neuronal development in a murine model of HIV-1 encephalitis.
Poluektova L; Meyer V; Walters L; Paez X; Gendelman HE
Glia; 2005 Dec; 52(4):344-53. PubMed ID: 16078235
[TBL] [Abstract][Full Text] [Related]
13. An experimental model system for HIV-1-induced brain injury.
Gendelman HE; Genis P; Jett M; Zhai QH; Nottet HS
Adv Neuroimmunol; 1994; 4(3):189-93. PubMed ID: 7874386
[TBL] [Abstract][Full Text] [Related]
14. Mononuclear phagocyte differentiation, activation, and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementia.
Ghorpade A; Persidskaia R; Suryadevara R; Che M; Liu XJ; Persidsky Y; Gendelman HE
J Virol; 2001 Jul; 75(14):6572-83. PubMed ID: 11413325
[TBL] [Abstract][Full Text] [Related]
15. Update on current models of HIV-related neuronal injury: platelet-activating factor, arachidonic acid and nitric oxide.
Lipton SA; Yeh M; Dreyer EB
Adv Neuroimmunol; 1994; 4(3):181-8. PubMed ID: 7874385
[TBL] [Abstract][Full Text] [Related]
16. Levels of human immunodeficiency virus type 1 (HIV-1) replication in macrophages determines the severity of murine HIV-1 encephalitis.
Nukuna A; Gendelman HE; Limoges J; Rasmussen J; Poluektova L; Ghorpade A; Persidsky Y
J Neurovirol; 2004; 10 Suppl 1():82-90. PubMed ID: 14982744
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective strategies for HIV-1 associated dementia.
Dou H; Kingsley JD; Mosley RL; Gelbard HA; Gendelman HE
Neurotox Res; 2004; 6(7-8):503-21. PubMed ID: 15639783
[TBL] [Abstract][Full Text] [Related]
18. Unraveling the mechanisms of neurotoxicity in HIV type 1-associated dementia: inhibition of neuronal synaptic transmission by macrophage secretory products.
Xiong H; Zheng J; Thylin M; Gendelman HE
AIDS Res Hum Retroviruses; 1999 Jan; 15(1):57-63. PubMed ID: 10024053
[TBL] [Abstract][Full Text] [Related]
19. HIV-Associated Neurotoxicity: The Interplay of Host and Viral Proteins.
Jadhav S; Nema V
Mediators Inflamm; 2021; 2021():1267041. PubMed ID: 34483726
[TBL] [Abstract][Full Text] [Related]
20. Cellular aspects of HIV-1 infection of macrophages leading to neuronal dysfunction in in vitro models for HIV-1 encephalitis.
Nottet HS; Bär DR; van Hassel H; Verhoef J; Boven LA
J Leukoc Biol; 1997 Jul; 62(1):107-16. PubMed ID: 9226001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
